TAGWORKS PHARMACEUTICALS B V has a total of 28 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2010. It filed its patents most often in WIPO (World Intellectual Property Organization), United States and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and micro-structure and nano-technology are HANDOK PHARMACEUTICALS CO LTD, ONTOGENESIS LLC and ALKEM LAB LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 10 | |
#2 | United States | 7 | |
#3 | EPO (European Patent Office) | 6 | |
#4 | Australia | 3 | |
#5 | Canada | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Micro-structure and nano-technology | |
#4 | Biotechnology | |
#5 | Measurement | |
#6 | Environmental technology |
# | Name | Total Patents |
---|---|---|
#1 | Robillard Marc Stefan | 27 |
#2 | Rossin Raffaella | 23 |
#3 | Versteegen Ronny Mathieu | 22 |
#4 | Ten Hoeve Wolter | 13 |
#5 | Hoeben Freek Johannes Maria | 8 |
#6 | Janssen Hendricus Marie | 6 |
#7 | Van Kasteren Sander Izaak | 4 |
#8 | Van De Graaff Michel Johan | 3 |
#9 | Van Onzen Arthur Henry Antoon Marie | 3 |
#10 | Lub Johan | 2 |
Publication | Filing date | Title |
---|---|---|
WO2020256545A1 | Agents for cleaving labels from biomolecules in vivo | |
WO2020256546A1 | Compounds for fast and efficient click release | |
WO2020256544A1 | Tetrazines for high click release speed and yield | |
CA3099421A1 | Compounds comprising a linker for increasing transcyclooctene stability | |
EP3787691A1 | Tetrazines for high click conjugation yield in vivo and high click release yield | |
WO2018004338A1 | Cleavable tetrazine used in bio-orthogonal drug activation | |
US2015297741A1 | Bio-orthogonal drug activation | |
EP2922574A1 | Chemically cleavable group | |
WO2014081300A1 | Channel protein activatable liposomes | |
WO2014081299A1 | Activatable liposomes | |
EP2419142A2 | Pretargeting kit, method and agents used therein |